(Q43258130)

17 November 2017

title

Effect of preoperative atorvastatin therapy on paraoxonase activity and oxidative stress after coronary artery bypass grafting (English)

1 reference

coronary artery bypass surgery

17 November 2017

main subject

1 reference

Sevil Kurban

1

1 reference

17 November 2017

Idris Mehmetoglu

series ordinal

2

1 reference

17 November 2017

Erdal Ege

series ordinal

3

1 reference

17 November 2017

language of work or name

1 reference

1 July 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

24

1 reference

17 November 2017

issue

4

1 reference

17 November 2017

page(s)

271-276

1 reference

Statins in coronary bypass surgery: rationale and clinical use.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Pre-operative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

A new automated colorimetric method for measuring total oxidant status

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0267659109350240

21 January 2018

Identifiers

DOI

10.1177/0267659109350240

1 reference

release_kmkviqlt25dhxnu2is7nupqjke

17 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kmkviqlt25dhxnu2is7nupqjke

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference